Shanghai Pharmaceuticals Hold Co., Ltd is a pharmaceutical industry group listed in Shanghai and Hong Kong, operating as a core enterprise under the controlling shareholder Shanghai Shangshi. The company's principal business covers three main segments: pharmaceutical manufacturing, distribution, and retail. It engages in the research, development, and production of drugs, while also managing a comprehensive supply chain for pharmaceutical products. The group serves the Chinese healthcare market, leveraging its integrated industry chain to connect manufacturing with distribution and retail channels. Key subsidiaries operate within these sectors, contributing to the group's diversified portfolio of healthcare products and services. The company focuses on expanding its international market presence and accelerating the commercialization of new products to address evolving healthcare needs.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Drug Manufacturers - General Homepage sphchina.com
Sector Healthcare IR page sphchina.com/investor_relations
Tags
innovative drugs, generic medicines, pharmaceutical distribution, pharmaceutical retail, healthcare supply chain, r&d
Press page —

Metrics

Valuation  
Market cap HK$ 40.714B
Market cap (USD) $ 5.189B
P/E 6.36
PEG —
P/BV 0.37
P/S 0.19
P/OCF 7.92
P/FCF —
Dividend yield 4.7%
Turnover / mcap 0.03%
Returns  
ROE —
ROI —
ROIC —
Profit margin —
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) -2.7%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 23.1%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue — — — — — — 186.566B 159.084B 130.847B 120.765B 105.517B 92.399B 78.223B 68.078B 54.9B 38.692B
Net profit — — 5.167B 6.992B 6.275B 5.605B 4.081B 3.881B 3.521B 3.196B 2.877B 2.591B 2.243B 2.053B 2.042B 1.456B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price 10.65 11.46 9.79 11.69 12.28 11.28 13.3 14.2 18.62 — — — — — — —
Price performance 12m -0.05 0.18 -0.21 -0.09 0.17 -0.15 -0.09 -0.25 — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Shanghai Pharmaceuticals Hold Co., Ltd (ticker 2607), listed in Hong Kong.

ETFs Holding Shanghai Pharmaceuticals Hold Co., Ltd

ETF Weight in ETF Shares Market value As of
DFSE 0.03% 117,800 $ 164.432K Nov 12, 2026
DFEV 0.02% 356,800 $ 498.041K Nov 12, 2026
DFEM 0.01% 767,000 $ 1.071M Nov 12, 2026
AVSE 0.01% 8,900 $ 12.501K Nov 16, 2026
DFAE 0.01% 570,800 $ 796.754K Nov 12, 2026
DFAX 0.00% 361,700 $ 504.881K Nov 12, 2026
AVEM 0.00% 697,600 $ 979.88K Nov 16, 2026